1. The Battle For Bristol-Myers Begins

    The Battle For Bristol-Myers Begins

    BMY has fallen on hard times of late, one of the weakest performers in healthcare. However, activist JANA Partners is quietly lurking. What will be the catalyst for JANA to finally get more involved? Bristol-Myers (NYSE: BMY ) has activist investor Barry Rosenstein and his JANA Partners as a shareholder. JANA hasn't announced any plans, or even considered the stake activist. Still, JANA could be playing wait-and-see...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned

  3. Authors